全肿瘤表观扩散系数直方图分析在R-ISS II期多发性骨髓瘤患者预后分层中的应用。

IF 2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Junde Zhou, Qin Wang, Yanting Liu, Lu Zhang, Jiao Li, Shuo Li, Dong Liu, Jinxia Zhu, Robert Grimm, Alto Stemmer, Shuang Xia, Wenyang Huang, Sheng Xie, Haibo Zhang, Jian Li, Huadan Xue, Zhengyu Jin
{"title":"全肿瘤表观扩散系数直方图分析在R-ISS II期多发性骨髓瘤患者预后分层中的应用。","authors":"Junde Zhou, Qin Wang, Yanting Liu, Lu Zhang, Jiao Li, Shuo Li, Dong Liu, Jinxia Zhu, Robert Grimm, Alto Stemmer, Shuang Xia, Wenyang Huang, Sheng Xie, Haibo Zhang, Jian Li, Huadan Xue, Zhengyu Jin","doi":"10.1016/j.mri.2025.110536","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to explore the utility of total tumor apparent diffusion coefficient (ttADC) histogram analysis based on whole-body diffusion-weighted magnetic resonance imaging (DWI-MRI) for prognostic stratification in patients with Revised International Staging System stage II (R-ISS II) multiple myeloma (MM).</p><p><strong>Methods: </strong>Patients with R-ISS II MM who underwent baseline whole-body MRI prior to treatment were retrospectively enrolled. The ttADC histogram parameters of the whole-body DWI-MRI were obtained using MR Total Tumor Load software (Siemens Healthcare, Erlangen, Germany). The overall survival (OS) and the progression-free survival (PFS) of the cohort was recorded. Cox regression analyses were used to evaluate the clinical features and ttADC histogram parameters for their association with OS and PFS.</p><p><strong>Results: </strong>A total of 61 R-ISS II MM patients were retrospectively included. During a mean follow-up period of 80 months, 27 patients died, 4 patients lost follow-up for OS, and 4 patients lost follow-up for PFS. Multivariate analysis revealed that increased median ttADC (≥0.620 × 10<sup>-3</sup> mm<sup>2</sup>/s) [hazard ratio (HR) = 2.291, P = 0.046, 95 % confidence interval (CI): 1.014-5.175] was independently associated with OS in R-ISS II MM patients. No significant association was observed between the ttADC histogram parameters and PFS.</p><p><strong>Conclusion: </strong>The median ttADC of whole-body DWI-MRI is an independent predictor of OS in R-ISS II MM patients, suggesting its potential role in further prognostic stratification in this patients' subgroup.</p>","PeriodicalId":18165,"journal":{"name":"Magnetic resonance imaging","volume":" ","pages":"110536"},"PeriodicalIF":2.0000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma.\",\"authors\":\"Junde Zhou, Qin Wang, Yanting Liu, Lu Zhang, Jiao Li, Shuo Li, Dong Liu, Jinxia Zhu, Robert Grimm, Alto Stemmer, Shuang Xia, Wenyang Huang, Sheng Xie, Haibo Zhang, Jian Li, Huadan Xue, Zhengyu Jin\",\"doi\":\"10.1016/j.mri.2025.110536\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aimed to explore the utility of total tumor apparent diffusion coefficient (ttADC) histogram analysis based on whole-body diffusion-weighted magnetic resonance imaging (DWI-MRI) for prognostic stratification in patients with Revised International Staging System stage II (R-ISS II) multiple myeloma (MM).</p><p><strong>Methods: </strong>Patients with R-ISS II MM who underwent baseline whole-body MRI prior to treatment were retrospectively enrolled. The ttADC histogram parameters of the whole-body DWI-MRI were obtained using MR Total Tumor Load software (Siemens Healthcare, Erlangen, Germany). The overall survival (OS) and the progression-free survival (PFS) of the cohort was recorded. Cox regression analyses were used to evaluate the clinical features and ttADC histogram parameters for their association with OS and PFS.</p><p><strong>Results: </strong>A total of 61 R-ISS II MM patients were retrospectively included. During a mean follow-up period of 80 months, 27 patients died, 4 patients lost follow-up for OS, and 4 patients lost follow-up for PFS. Multivariate analysis revealed that increased median ttADC (≥0.620 × 10<sup>-3</sup> mm<sup>2</sup>/s) [hazard ratio (HR) = 2.291, P = 0.046, 95 % confidence interval (CI): 1.014-5.175] was independently associated with OS in R-ISS II MM patients. No significant association was observed between the ttADC histogram parameters and PFS.</p><p><strong>Conclusion: </strong>The median ttADC of whole-body DWI-MRI is an independent predictor of OS in R-ISS II MM patients, suggesting its potential role in further prognostic stratification in this patients' subgroup.</p>\",\"PeriodicalId\":18165,\"journal\":{\"name\":\"Magnetic resonance imaging\",\"volume\":\" \",\"pages\":\"110536\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Magnetic resonance imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.mri.2025.110536\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magnetic resonance imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.mri.2025.110536","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在探讨基于全身弥散加权磁共振成像(DWI-MRI)的肿瘤总表观扩散系数(ttADC)直方图分析在修订国际分期系统II期(R-ISS II)多发性骨髓瘤(MM)患者预后分层中的应用。方法:回顾性纳入治疗前接受基线全身MRI检查的R-ISS II型MM患者。使用MR Total Tumor Load软件(Siemens Healthcare, Erlangen, Germany)获得全身DWI-MRI的ttADC直方图参数。记录该队列的总生存期(OS)和无进展生存期(PFS)。采用Cox回归分析评估临床特征和ttADC直方图参数与OS和PFS的关系。结果:回顾性分析了61例R-ISS II型MM患者。在平均80 个月的随访期间,27例患者死亡,4例患者因OS失去随访,4例患者因PFS失去随访。多因素分析显示,中位ttADC升高(≥0.620 × 10-3 mm2/s)[风险比(HR) = 2.291,P = 0.046,95 %可信区间(CI): 1.014-5.175]与R-ISS II型MM患者的OS独立相关。ttADC直方图参数与PFS之间无显著相关性。结论:全身DWI-MRI的中位ttADC是R-ISS II型MM患者OS的独立预测因子,提示其在该患者亚组进一步预后分层中的潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma.

Purpose: This study aimed to explore the utility of total tumor apparent diffusion coefficient (ttADC) histogram analysis based on whole-body diffusion-weighted magnetic resonance imaging (DWI-MRI) for prognostic stratification in patients with Revised International Staging System stage II (R-ISS II) multiple myeloma (MM).

Methods: Patients with R-ISS II MM who underwent baseline whole-body MRI prior to treatment were retrospectively enrolled. The ttADC histogram parameters of the whole-body DWI-MRI were obtained using MR Total Tumor Load software (Siemens Healthcare, Erlangen, Germany). The overall survival (OS) and the progression-free survival (PFS) of the cohort was recorded. Cox regression analyses were used to evaluate the clinical features and ttADC histogram parameters for their association with OS and PFS.

Results: A total of 61 R-ISS II MM patients were retrospectively included. During a mean follow-up period of 80 months, 27 patients died, 4 patients lost follow-up for OS, and 4 patients lost follow-up for PFS. Multivariate analysis revealed that increased median ttADC (≥0.620 × 10-3 mm2/s) [hazard ratio (HR) = 2.291, P = 0.046, 95 % confidence interval (CI): 1.014-5.175] was independently associated with OS in R-ISS II MM patients. No significant association was observed between the ttADC histogram parameters and PFS.

Conclusion: The median ttADC of whole-body DWI-MRI is an independent predictor of OS in R-ISS II MM patients, suggesting its potential role in further prognostic stratification in this patients' subgroup.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Magnetic resonance imaging
Magnetic resonance imaging 医学-核医学
CiteScore
4.70
自引率
4.00%
发文量
194
审稿时长
83 days
期刊介绍: Magnetic Resonance Imaging (MRI) is the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research, technological innovation and applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信